Darrin R. Uecker holds 753,317 shares of Pulse Biosciences, making him significantly invested in the company. In 2022, his wealth in stock options was noteworthy but complicated due to the company's performance, which did not meet the criteria for cash...

Darrin R. Uecker holds 753,317 shares of Pulse Biosciences, making him significantly invested in the company. In 2022, his wealth in stock options was noteworthy but complicated due to the company's performance, which did not meet the criteria for cash bonuses or stock awards. In previous years, his total compensation peaked at about $2.8 million in 2021, with a notable portion derived from stock options that reflected high market values at the time. His ownership percentage is roughly 2.8% of the company, a tangible sign of his commitment to its success. Uecker's financial stake shows the ups and downs of the biotech industry, where the right innovations can significantly alter the value of one’s holdings, illustrating the inherent risks and rewards of executive leadership in this fast-paced field.